Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction.
Li
Qun
Q
Division of Pharmaceutical Sciences, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, Laramie, WY 82071, USA.
Turdi
Subat
S
Thomas
D Paul
DP
Zhou
Tianjie
T
Ren
Jun
J
D000818:Animals; D002118:Calcium / Q000378:metabolism; D007267:Injections; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D051379:Mice; D008810:Mice, Inbred C57BL; D009200:Myocardial Contraction / Q000502:physiology; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy*; D009206:Myocardium / Q000473:pathology*; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000473:pathology*; D014463:Ultrasonography; D018487:Ventricular Dysfunction, Left / Q000628:therapy*; D020257:Ventricular Remodeling
D002118:Calcium